13F filer · CIK 1577524
Sarissa Capital Management LP
GREENWICH, CT · filing since Q4 2013 · last filing Aug 14, 2026
Reported value
$177.9M
+$20.2M vs prior
Positions
10
New / sold out
1 / 0
Added / reduced
1 / 1
Turnover
0.3%
buys $489.9K · sells $5.5M
Top-10 weight
100.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | BIOHAVEN LTD | +19,128 | +3.4% | +$284.6K |
| New | BIOGEN INC | +950 | – | +$205.3K |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | INNOVIVA INC | -240,346 | -11.3% | $-5.5M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | INNOVIVA INCCOM | 1,890,604 | $42.9M | 24.14% |
| 2 | IRONWOOD PHARMACEUTICALS INCCOM CL A | 9,188,635 | $38.7M | 21.75% |
| 3 | AMARIN CORP PLCSPONSORED ADR | 1,673,395 | $26.7M | 15.00% |
| 4 | NEUROCRINE BIOSCIENCES INCCOM | 116,533 | $19.6M | 11.04% |
| 5 | CYTOKINETICS INCCOM NEW | 228,623 | $19.5M | 10.95% |
| 6 | LANTHEUS HLDGS INCCOM | 166,919 | $18.5M | 10.41% |
| 7 | BIOHAVEN LTDCOM | 582,312 | $8.7M | 4.87% |
| 8 | REGENERON PHARMACEUTICALSCOM | 4,190 | $2.6M | 1.47% |
| 9 | VOR BIOPHARMA INCCOM NEW | 25,399 | $467.6K | 0.26% |
| 10 | BIOGEN INCCOM | 950 | $205.3K | 0.12% |